Neurodegenerative diseases Flashcards

1
Q

Drug classes in treatment for Alzheimees

A
  1. Cholinesterase Inhibitors
  2. NMDA receptor Antagonist
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cholinesterase inhibitors

A
  1. Donepezil (Aricept)
  2. Rivastigmine (Exelon)
  3. Galantamine (Razadylne)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

NMDA receptor antagonist

A

Memantine (Namenda)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Mechanism of action for cholinesterase inhibitors

A
  1. Prevents action of acetylcholinesterase
  2. this increases acetlycholine in the synapse
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Nausea

Bronchospasm

A

Cholinesterase inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Headache, Dizziness, Diarrhea

A

Cholineaterase inhibitors

and

NMDA receptor antagonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
  1. sedation
  2. fatigue
  3. hypertension
  4. rash
  5. weight gain
  6. urinary frequency
  7. anemia
A

NMDA receptor antagonists- Memantine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Memantine (Namenda) mechanism of action

A
  1. Block leaky channels to reduce calcium induced excitotoxicity
  2. Block leaky channels to reduce background noise and make signals relatively stronger
  3. Blocks the pathalogical activation of NMDA receptors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is drug therapy for parkinsons aimed at

A

increasing dopamine or decreasing Acetylcholine to balance the two

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Three mechanisms of action of dopiminergic agents

A
  1. increase amounts of dopamine in th Striatum
  2. incresed delivery or decreased degredation of dopamine
  3. Mimic the effects of dopamine - dopamine agonists
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is the mechanism of action of anticholonergic agents

A

Prevent cholonergic inhibition of dopamine release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

First line of therapy for Parkinsons

A

Levadopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

80% of paitines show improvement, and 20% Regain normal function with levadopa therapy, but what else is very improtant about this therapy

A

Its effects wer off over time (2-3 years) likely due to advanced neuro degeneration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Levadopa mechanism of action

A

levadopa is converted to dopamine increasing dopamine in the striatum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Levadopa is converted to ____________providing dopamine in the striatum, this happens in the _________________. Levadopa is only needed in the _________ and large amounts of levadopa in the __________ causes problems. This is why Levadopa is dosed with ___________ a ________________ and ___________a ___________ which causes sthe same amount of Levadopa to reach the brain with a ____________ dose. ___________ is added when ________________ wanes.

A
  1. dopamine
  2. periphery and the brain.
  3. brain
  4. periphery
  5. Carbadopa a peripheral decarboxylase inhibitor
  6. Entacopne a COMT inhibitor
  7. smaller
  8. Entacapone
  9. Levadopa/Carbadopa
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Acute side effects of Levadopa

A

Disappear after a few week s and include nausea, anorexia and hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Sede effects of Levadopa

A
  1. involutary movements
  2. on-off effects (hypokinesia and improvements)
  3. Psychosis - schizophrinia like symptoms with excess domamine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Adverse drug interaction with Levadopa

A

MAO Inhibitors- will cause an overload of dopamine and NE

19
Q

Levadopa when given alone is degraded by

A

Mosty decarboxylases and a little by COMT causing ittle to get to the brain

20
Q

When levadopa is given with a DDC inhipibitor (Decarboylase inhibitor) ____________.

A

Dopamine is still broken down by COMT and not as much gets to the brain

21
Q

Optimization of levadopa happens when

A

Levadopa is given with a DDC inhibitor and a COMT inhibitor - this allows for the most amount of the drug to get to the brain

22
Q

Dopamine agonists

A

Pramipexole and Ropinirole

23
Q

Highly selective for D2/D3 receptors

A

Pramipexole and Ropinirole

24
Q

may cuase halucinations and compulsive behaviors

A

Pramipexole and Ropinirole

25
Q

Increases dopamine in the synapes

A

Selegiline

26
Q

MAO-B inhibitor

A

Selegiline

27
Q

Because _________ is an MAO-B inhibitor it is not involed in _______________. It specifically decreases ____________. and does not have the _____________________

A
  1. Selegiline
  2. NE metabolism
  3. Dopamine degredation
  4. unwanted effects of non-selctive MAOIs
28
Q

Enhances dopamine release into the synapse

A

Amantadine

29
Q

Anticholinergic drug used for parkinsons

A

Benzotropine

30
Q

MOA for anticholinergic drug for parkinsons

A

Benzotropine - causes a blockade of muscarinic receptors relieving the inhabition of dopaminergic neurons causing more dopamine release

31
Q

Muscarinic receptors

A

in striatum where they inhibit dopamine release from dopamine neurons

32
Q

Benzotropine side effects

A

Anticholinergic - Anti SLUDG

  1. dry mouth
  2. dry eyes
  3. urinary retention
  4. constipation
33
Q

Clearance can be reduced by increasing urinary pH - ie giving bicarbonate

A

Memantine

34
Q

Prolongtion of Succinylcholine

A

Cholinesterase inhibitors - Donepexil, Rivastigmine, Galamtamine

35
Q

Assess for anticholinergic siede effects especially HR

A

Anticholinergic drugs like Benztropine - Decreased HR

36
Q

avaoid drugs that impact cholinergic tone like TCA’s

A

Anticholinergic drugs - Benztropine

37
Q

Evaluate for anticholinergic-like side effects

A

Amantadine

38
Q

Rule out congestive heart failure side effect

A

Amantadine

39
Q
  1. MUST receive q6-12 hours
  2. Administer 20 minutes pre-op and intraop to avoid SUDDEN sloss of effect and neuromuscular/respiratory failure
A

Levadopa decarboxylase inhibitors

40
Q

effects include

  1. cardiac dysrhythmias
  2. adrenergic stimulation
  3. orthostatic hypotension
  4. GI
A

Levadopa decarboxylase inhibitors

41
Q

Side effects include

  1. CV
  2. hypotension
  3. pleuropulmonary fibrosis
A

Synthetic dopamine agonists -Pramipexole and ropinirole

42
Q

AVOID Ephedrine and Mepreidine

A

Selegiline (MAO-B inhibitor)

43
Q

Use extreme caution with vasoactive medications

A

Selegiline (MAO-B inhibitor)

44
Q

Pronounced effect with neuromuscular blockers, sedative agent, diuretics

A

Selegiline (MAO-B inhibitor)